News

Gilead Sciences, Inc. is set to present new data at the San Antonio Breast Cancer Symposium (SABCS) 2023, highlighting...

At the upcoming 65th American Society of Hematology (ASH) Annual Meeting, AstraZeneca will present a wealth of new clinical...

Compassionate use, also known as expanded access, is a critical pathway for patients with life-threatening conditions to access investigational...

The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Pfizer’s Elrexfio, a groundbreaking bispecific antibody therapy...

Viatris Inc. and Mapi Pharma Ltd. have heralded a significant advancement in the treatment of relapsing forms of multiple...